Source: Annual Congress 2010 - Models of airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Fernandes, L. Fievez, F. Bureau, R. Vanbever (Brussels, Liège, Belgium). Sirtuins inhibition modulates endotoxin-induced lung inflammation. Eur Respir J 2010; 36: Suppl. 54, 3709

Member's Comments

No comment yet.

Related content which might interest you: Gut microbial modulation attenuates emphysema development by suppressing inflammation and apoptosis Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 iNOS inhibition modulates lung tissue inflammation via oxidative stress pathway activation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Arginase inhibition modulates lung strip mechanics in animals with chronic pulmonary inflammation Source: Annual Congress 2008 - Pathophysiology of respiratory diseases Year: 2008 Impaired lung function is associated with systemic inflammation and macrophage activation Source: Eur Respir J 2015; 45: 557-559 Year: 2015 Modulation of oxidative stress pathway by arginase inhibition: Evaluation in an animal model of chronic pulmonary inflammation Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 CD101 eosinophil serves as an early response to suppress endotoxin-induced acute lung injury Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Effect of curcumin on LPS-induced neutrophil activation and acute lung injury Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation Year: 2012 IL-33/sST2 balance regulates neutrophilic inflammation in the human airways. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Eur Respir Rev 2006; 15: 207-208 Year: 2006 Effect of phosphodiesterase-4 inhibitor on the inflammation, oxidative damage and apoptosis in a saline lavage-induced model of acute lung injury Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Activated protein C protection in endotoxin-induced lung injury is mediated by lung matrix metalloproteinases activity Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 PPAR-gamma modulates allergic inflammation through upregulation of PTEN Source: Eur Respir J 2005; 26: Suppl. 49, 25s Year: 2005 Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 RAGE deficiency improves alveolar fluid clearance in LPS-induced acute lung injury by preventing downregulation of Na-K-ATPase and ENaC Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017 Regulation of inflammation Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases Year: 2004 Effects of corticosteroid or montelukast associated to iNOS inhibition on inflammation and remodelling of distal lung in animals with chronic inflammation Source: Annual Congress 2010 - Models of airways disease Year: 2010 The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020